Methenamine Hippurate Eql Pharma

Methenamine Hippurate, the active ingredient in Methenamine Hippurate Eql Pharma, is a urinary antiseptic presented as an oral tablet for oral use. It is used to prevent recurrent urinary tract infections in adults.

GNH USA supplies Methenamine Hippurate Eql Pharma as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Methenamine Hippurate is a urinary antiseptic indicated for prophylaxis of urinary tract infections. - Recurrent urinary tract infections: reduces the frequency of infections in patients with a history of recurrence. - Catheter‑associated urinary infections: helps maintain sterile urine during short‑term catheterisation. - Post‑surgical urinary prophylaxis: used to prevent infection after urological procedures.

Methenamine Hippurate may cause adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild stomach upset. - Dyspepsia: discomfort or burning in the upper abdomen. - Metallic taste: transient alteration of taste perception. - Headache: mild to moderate intensity. - Skin rash: localized erythema or pruritus.

Serious or Rare Side Effects: - Hematuria: blood in urine, indicating possible urinary irritation. - Severe allergic reaction: anaphylaxis, swelling of face or throat. - Metabolic acidosis: rare disturbance of acid‑base balance. - Renal impairment: worsening kidney function in susceptible individuals. - Hepatotoxicity: elevated liver enzymes in rare cases.

Before using Methenamine Hippurate, consider the following precautions. - Acidic urine requirement: ensure urine pH is below 6.0 for optimal drug activation. - Renal function: assess kidney function; dose adjustment may be needed in impairment. - Hepatic function: monitor liver enzymes in patients with liver disease. - Pregnancy and lactation: use only if clearly needed; discuss risks with a healthcare professional. - Concomitant urinary alkalinising agents: avoid or monitor as they may reduce efficacy. - Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture.

Methenamine Hippurate can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Urinary alkalinizers (e.g., sodium bicarbonate, potassium citrate): raise urine pH, reducing drug activation. - High‑dose vitamin C: may increase urinary pH and diminish effectiveness.

Moderate Interactions (Monitor Closely): - Loop diuretics: may alter urinary concentration, affecting drug hydrolysis. - Antacids containing magnesium or aluminum: can affect urinary pH indirectly. - Other urinary antiseptics: combined use may increase risk of adverse renal effects.